Market growth is propelled by the increasing prevalence of severe chronic respiratory diseases (CRDs) such as asthma, COPD, cystic fibrosis, and pulmonary hypertension, driven by factors like aging populations, tobacco use, pollution, occupational exposure, and advancements in homecare technologies. Nevertheless, the digital respiratory devices market faces challenges including high costs, limited reimbursement options, data security issues, and the need for improved patient adherence.
The global Digital Respiratory Devices Market study provides market data for by Product (Smart Inhalers & Nebulizers, Sensors & Apps), by Indication (Asthma, COPD, Other Diseases), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by End Use (Hospitals, Homecare Settings, Other Settings)
On the basis of Product: With a majority share and the fastest growth, the smart inhalers and nebulizers segment leads the market. Increased respiratory illnesses, air pollution, and patient adherence are some of the factors causing this. In comparison to conventional inhalers, smart inhalers enhance drug adherence and inhalation technique. The aging of the population, expanding life expectancy, and growing need for continuous respiratory monitoring are expected to drive the sensors and apps segment's greatest compound annual growth rate.
By Indication: The digital respiratory devices market is segmented by indication, with COPD leading in 2022. 200 million people worldwide have COPD, and respiratory disorders account for over 8% of chronic diseases. The WHO predicts COPD will be the fourth leading cause of death globally by 2030.
By Distribution Channel: Hospital pharmacies currently lead the market, generating over 35% of revenue in 2021. This is attributed to an aging population and the rise in chronic respiratory diseases. The online pharmacy segment is expected to grow the fastest, with a CAGR of 31.1%, driven by the expansion of e-pharmacies, increased e-prescriptions, and the growing popularity of online services.
By end user: Hospitals dominated the market in 2021, holding over 50% of the revenue share. This segment is poised for growth driven by factors like improved healthcare access and infrastructure advancements. The market encompasses hospitals, homecare, and other settings.
Global Digital Respiratory Devices Market Key Players:
3M Health Care Limited, Adherium Limited, Amiko Digital Health Limited, AireHealth, Inc., Cognita Labs, COHERO Health Inc., FindAir Sp. z o.o, Novartis AG, Pneuma Respiratory Inc., Propeller Health, Teva Pharmaceuticals Industries Ltd., Others.
Global Digital Respiratory Devices Market Segmentation:
By Product: Based on the Product, Global Digital Respiratory Devices Market is segmented as; Smart Inhalers & Nebulizers, Sensors & Apps.
By Indication: Based on the Indication, Global Digital Respiratory Devices Market is segmented as; Asthma, COPD, Other Diseases.
By Distribution Channel: Based on the Distribution Channel, Global Digital Respiratory Devices Market is segmented as; Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.
By End Use: Based on the End Use, Global Digital Respiratory Devices Market is segmented as; Hospitals, Homecare Settings, Other Settings.
By Region: This research also includes data for North America, Asia-Pacific, Latin America, Middle East & Africa and Europe.
This study also encompasses various drivers and restraining factors of this market for the forecast period. Various growth opportunities are also discussed in the report.